FAKTOR-OPTIONSSCHEIN - AMGEN | Market Closed - Deutsche Boerse AG 20:43:59 28/05/2024 BST | ||
| 0.5 EUR | -21.88% |
|
| Current month | +66.67% | ||
| 1 month | +92.31% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
Latest news about AMGEN INC.
More news
| Date | Price | Change |
|---|---|---|
| 28/05/24 | 0.5 | -21.88% |
| 27/05/24 | 0.64 | +1.59% |
| 24/05/24 | 0.63 | -4.55% |
| 23/05/24 | 0.66 | -13.16% |
| 22/05/24 | 0.76 | -12.64% |
Delayed Quote Deutsche Boerse AG
Last update May 28, 2024 at 08:43 pm
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | AMGEN INC. |
| Issuer | 
Société Générale
|
| WKN | SQ6CH2 |
| ISIN | DE000SQ6CH22 |
| Date issued | 14/12/2022 |
| Strike | 276.6 $ |
| Maturity | Unlimited |
| Parity | 1 : 1 |
| Emission price | 10.27 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 10.18 € |
|---|---|
| Lowest since issue | 0.19 € |
| Spread | 0.02 € |
| Spread % | 3.77% |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
300.2
USD
Average target price
316.3
USD
Spread / Average Target
+5.36%
- Stock Market
- Certificates
- Certificat
